Radiation therapy and memory in nasopharyngeal cancer patients
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at how a specific type of radiation therapy (called IMRT) for nasopharyngeal cancer might affect memory and thinking. It aims to see if this treatment causes any changes in cognitive function over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be newly diagnosed with nasopharyngeal cancer (a type of throat cancer) and have not yet started treatment.
- Your cancer must be at a stage that has not spread to other parts of the body (stage I to IVa).
- You must be between 18 and 60 years old.
- You must be of Han Chinese ethnicity and right-handed.
- You must have at least a junior high school education.
- You must not have any history of brain disease, head injury, or mental illness, and no other serious health conditions like diabetes or high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a newer, more precise type of radiation (proton therapy) works better than standard radiation (IMRT) for people with advanced nasopharyngeal cancer. It also includes chemotherapy and immunotherapy to see if the combination can improve outcomes.
This trial tests a combination of high and low dose radiation plus an immunotherapy drug (PD-1 inhibitor) for people whose nasopharyngeal cancer has come back after previous treatment. The goal is to see if this approach can be more effective while reducing side effects.
This study looks at tissue and blood samples from people already treated for nasopharyngeal carcinoma to find markers that predict how well treatment works and to identify new ways to treat the cancer. It may help doctors personalise care in the future.
This trial tests whether a smaller radiation treatment area is as effective as the usual larger one for people whose metastatic nasopharyngeal cancer has responded well to first-line chemotherapy plus immunotherapy. It aims to reduce side effects while keeping the cancer under control.
This trial tests whether people with early-stage nasopharyngeal cancer can receive a lower dose of radiation after chemotherapy, which may reduce side effects while still treating the cancer effectively.
This trial tests whether a personalized radiation plan for the neck can prevent cancer from spreading in people with nasopharyngeal carcinoma. It's for those whose cancer hasn't spread beyond the head and neck area.
Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.